Vik Vaz

Vik Vaz is a physician-turned-executive who became CEO and President of San Diego multi-omics biotech Pleno Inc. in December 2024, arriving the same day the company closed a $25M Series B. Trained as a surgeon and interventional oncologist, he later ran strategy and companion diagnostics at Illumina and was a partner at both McKinsey and Boston Consulting Group. At Pleno he is commercializing the RAPTOR platform, which uses proprietary Hypercoding technology to detect DNA, RNA and protein targets in a single sample at high speed and low cost.